Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNK

Michael Korenjak,Nuri A Temiz,Stephane A. Keita,Berenice Chavanel,Claire Renard,Cecilia Sirand,Vincent Cahais,Tanguy Mayel,Karin Vevang,Foster C. Jacobs,Jiehong Guo,William E. Smith,Marissa K. Oram,Flaviu Tabaran,Ozan Ahlat,Ingrid Cornax,M. Gerard O'Sullivan,Samrat Das,Shuvro P. Nandi,Yuhe Cheng,Ludmil B. Alexandrov,Silvia Balbo,Stephen S. Hecht,Sergey Senkin,Francois Virard,Lisa A. Peterson,Jiri Zavadil

DOI: https://doi.org/10.1101/2024.06.28.600253

2024-06-28

Abstract:Tobacco usage is linked to multiple cancer types and accounts for a quarter of all cancer-related deaths. Tobacco smoke contains various carcinogenic compounds, including polycyclic aromatic hydrocarbons (PAH), though the mutagenic potential of many tobacco-related chemicals remains largely unexplored. In particular, the highly carcinogenic tobacco-specific nitrosamines NNN and NNK form pre-mutagenic pyridyloxobutyl (POB) DNA adducts. In the study presented here, we identified genome-scale POB-induced mutational signatures in cell lines and rat tumors, while also investigating their role in human cancer. These signatures are characterized by T greater than N and C greater than T mutations forming from specific POB adducts damaging dT and dC residues. Analysis of 2,780 cancer genomes uncovered POB signatures in approx 180 tumors; from cancer types distinct from the ones linked to smoking-related signatures SBS4 and SBS92. This suggests that, unlike PAH compounds, the POB pathway may contribute uniquely to the mutational landscapes of certain hematological malignancies and cancers of the kidney, breast, prostate and pancreas.

Genomics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to identify the mutational signatures left by tobacco - specific nitrosamines (NNN and NNK) in the human cancer genome. Specifically, the researchers experimentally generated the mutational signatures caused by these compounds and verified these signatures in cell lines and rat tumors. Then, they further analyzed 2,780 human cancer genomes to determine whether these mutational signatures exist in specific types of cancer, especially those cancers other than the smoking - related cancer types.

### Research Background
Tobacco use is associated with multiple cancer types and accounts for one - fourth of all cancer - related deaths. Tobacco smoke contains a variety of carcinogenic compounds, such as polycyclic aromatic hydrocarbons (PAH), but the mutagenic potential of many tobacco - related chemicals remains largely unexplored. In particular, the highly carcinogenic tobacco - specific nitrosamines NNN and NNK form pre - mutagenic pyridyloxobutyl (POB) DNA adducts. These adducts damage dT and dC residues, resulting in specific mutation types, such as T > N and C > T mutations.

### Research Objectives
1. **Identify POB - induced mutational signatures**: The researchers identified the genome - wide mutational signatures caused by POB in cell lines and rat tumors.
2. **Investigate the role of these signatures in human cancers**: By analyzing 2,780 cancer genomes, the researchers explored the presence of these mutational signatures in different types of cancers, especially those cancer types different from the known smoking - related mutational signatures (such as SBS4 and SBS92).

### Main Findings
- **Experimentally generated mutational signatures**: The researchers successfully generated POB - induced mutational signatures in cell lines and rat tumors, which are mainly manifested as T > N and C > T mutations.
- **Mutational signatures in the human cancer genome**: In 2,780 cancer genomes, the POB signatures were detected in approximately 180 tumor samples, and these tumors mainly come from certain hematological malignancies as well as kidney, breast, prostate and pancreatic cancers.
- **Relationship with other smoking - related mutational signatures**: The POB signatures exist independently of the known smoking - related mutational signatures (such as SBS4 and SBS92) in certain cancer types, indicating that the POB pathway may have a unique contribution in the mutational landscape of certain cancer types.

### Conclusion
This study, through experiments and genomic analysis, reveals the unique mutational signatures left by tobacco - specific nitrosamines NNN and NNK in the human cancer genome. These findings not only enhance the understanding of the tobacco carcinogenesis mechanism but also provide new directions for future research, especially in non - smoking - related cancer types.